Last reviewed · How we verify
NCT05298605
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
NA trial testing Faith in Action! Church-based Navigation Model in Breast Cancer Female in 320 participants. Currently enrolling.
1 July 2025
Quick facts
| Lead sponsor | Cedars-Sinai Medical Center |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 320 |
| Start date | 16 July 2022 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Faith in Action! Church-based Navigation Model
- Control
Conditions studied
- Breast Cancer Female — all drugs for Breast Cancer Female →
- Health Knowledge, Attitudes, Practice — all drugs for Health Knowledge, Attitudes, Practice →
- Cancer Screening — all drugs for Cancer Screening →
- Health Disparities — all drugs for Health Disparities →
Sponsor
Cedars-Sinai Medical Center
Who can join
Adults 45 to 80, female only, with Breast Cancer Female or Health Knowledge, Attitudes, Practice. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to develop a culturally adapted "Faith in Action!" curriculum to train lay health navigators to provide breast cancer screening navigation to Korean American women within faith-based settings and evaluate whether the culturally adapted "Faith in Action!" curriculum increases adherence to breast cancer screening guidelines among Korean American women within faith-based settings in Los Angeles, California. The primary research procedures include trainings and key informant interviews with lay health navigators in faith-based settings followed by a cluster randomized trial to evaluate the intervention.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Protocol for a cluster randomized trial to evaluate a faith-based breast cancer screening navigation model.
Gresham G, Kim DH, Sung MJ, Diniz MA, et al · · 2026 · PMID 41612469 · DOI 10.1186/s13063-025-09397-2 -
Protocol for a Cluster Randomized Trial to Evaluate a Faith-Based Breast Cancer Screening Navigation Model
Gresham G, Kim DH, Sung MJ, Diniz M, et al · · 2025 · DOI 10.21203/rs.3.rs-7403193/v1
Verify or expand the search:
- PubMed search for NCT05298605
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Female
Currently open trials in the same condition.
- NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
- NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
- NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting
Other Cedars-Sinai Medical Center trials
Trials by the same sponsor.
- NCT06012487 — Correlates and Control of Blood Pressure Variability · Phase 1 · not yet recruiting
- NCT07495995 — SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis · Phase 2 · not yet recruiting
- NCT07413965 — TAVR vs SAVR in Severe Bicuspid Aortic Stenosis · NA · not yet recruiting
- NCT06521021 — CHOICE to AVOID or RESIST · NA · not yet recruiting
- NCT07499089 — Together-Breast Cancer Support Platform · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05298605 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cedars-Sinai Medical Center
- Last refreshed: 27 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05298605.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing